To homepage

Discover the Best Stem cell therapy for ALS (amyotrophic lateral sclerosis) Clinics in the World

The Bookimed clinic ranking is based on data science algorithms, providing a trusted, transparent, and objective comparison. It takes into account patient demand, review scores (both positive and negative), the frequency of updates to treatment options and prices, response speed, and clinic certifications.

How to Choose the Right Clinic for Stem cell therapy for ALS (amyotrophic lateral sclerosis): 6 Insider Tips

Looking for the safest, most trusted clinics specializing in Stem cell therapy for ALS (amyotrophic lateral sclerosis)? Keep these key points in mind:
Compare techniques
Top clinics offer multiple Stem cell therapy for ALS (amyotrophic lateral sclerosis) methods – ask why one fits your case better.
Check surgeon's case volume
Ask about your surgeon's personal case volume and success rates, not just clinic-wide stats.
Review similar cases
Ask to see before-and-after results matching your specific anatomy or condition.
Confirm aftercare options
Ask about follow-up schedule, remote consultations, and support after you return home.
Review pricing details
Transparent pricing means itemized quotes – check what's included and what's not.
Read verified patient reviews
Best-reviewed clinics have detailed feedback on communication, recovery, and results.
Finding the right clinic for Stem cell therapy for ALS (amyotrophic lateral sclerosis) abroad takes research. With more than 1,000,000 patient inquiries since 2014, we know which clinics have the expertise, technology, and outcomes for cases like yours. We're here to help you find trusted options that fit your needs and budget.

Top 25 Clinics for Stem cell therapy for ALS (amyotrophic lateral sclerosis) in the World 2026 — Bookimed Insights

Based on 68+ patient requests for Stem cell therapy for ALS (amyotrophic lateral sclerosis) and data from 25 accredited partner clinics, Bookimed identified these top centers for treatment outcomes, doctor expertise, and patient experience. The table reflects real 2024-2026 treatment programs. Final costs depend on your individual case and treatment plan. Request a free quote for personalized pricing.
RankClinic NamePatient RatingCountryLead DoctorexperienceTechniquesBest ForWhy It’s RankedAccreditations
#1
4.6 / 5
(436)
Istanbul, Turkey
37+ years
Umbilical cord-derived mesenchymal stem cell (UC-MSC) transplantationGenetic ALS casesA 4-session plan using umbilical cord-derived stem cells (1–2 million cells/kg per session). Treatment includes EMG and genetic analysis to target genetic ALS forms. JCI-accredited hospital.International Organization for Standardization, Joint Commission International
#2
4.9 / 5
(11)
Monterrey, Mexico
10+ years
DEZAWA MUSE Cell and Exosome Competence Therapy—DEZAWA MUSE therapy delivers 100 million cells and 1 trillion exosomes targeting neuroinflammation. Founder has performed 900+ treatments.—
#3
4.4 / 5
(3)
Bangkok, Thailand
7+ years
Fresh, non-frozen umbilical cord-derived mesenchymal stem cells (UC-MSCs)—Uses fresh, non-frozen umbilical cord stem cells (UC-MSCs) with high viability. Releases GDNF and BDNF to protect motor neurons. Laboratory operates under ISO 9001:2015, OECD GLP, and ISO/IEC 17025:2017.ISO 9001:2015 Quality management systems
#4
5.0 / 5
(2)
Bangkok, Thailand
—
—
Peripheral blood stem cell therapy, live cell therapy—Offers PBSC therapy with GMP-certified cell rejuvenation, performed in Germany under specialist supervision for ALS and other nerve degenerative diseases.ISO 9001:2015 Quality management systems
#5
5.0 / 5
(1)
Bangkok, Thailand
15+ years
UC-MSC therapy, intravenous infusion—Neurosurgeon-led program for specialist ALS management. Uses GMP-certified umbilical cord stem cells to target inflammation and support neurological function.ISO 9001:2015 Quality management systems
#6
5.0 / 5
Monterrey, Mexico
53+ years
Mesenchymal stem cells (MSC), MUSE cells, exosomesExosome-based therapy with direct brain deliveryExosomes cross the blood-brain barrier to deliver targeted neuroprotection for ALS. MUSE cells can differentiate into neural tissue. 78% of neurodegenerative patients report functional improvement.—
#7
5.0 / 5
Medellín, Colombia
12+ years
Mesenchymal stem cells, exosomesALS patients seeking mobility enhancementUses high-potency stem cells with a replication factor of 12, significantly more effective than standard treatments. Offers a service guarantee with complimentary re-treatment if results aren't achieved.—
#8
4.3 / 5
(4)
Kyiv, Ukraine
—
—
Fetal stem cell therapy, intrathecal delivery—Holds a patented fetal stem cell method for ALS. Intrathecal delivery option for advanced cases with 4–6 months of stable improvement.—
#9
4.8 / 5
(34)
Eskisehir, Turkey
—
—
Stem cell therapy for ALS (amyotrophic lateral sclerosis)——International Organization for Standardization, Turkish Medical Association
#10
5.0 / 5
(3)
Madrid, Spain
—
—
Stem cell therapy for ALS (amyotrophic lateral sclerosis)——Joint Commission International , International Organization for Standardization